Review of prognostic tools for the clinical management of patients with AILD. In AIH, LiverMultiScan cT1, an objective, accurate measure of fibro-inflammation, may be determinant in clinical decision-making and could substitute liver biopsy in follow-up. It also outlines the prognostic value of MRCP+ for PSC management.
Welcome to Perspectum Medical Education
You are entering a website that is scientific in nature and created for healthcare professionals.
Are you a healthcare professional?